Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Growth Metrics

Others

Healthy Extracts (HYEX) Capital Expenditures (2019 - 2022)

Healthy Extracts filings provide 2 years of Capital Expenditures readings, the most recent being $7987.0 for Q1 2022.

On a quarterly basis, Capital Expenditures changed N/A to $7987.0 in Q1 2022 year-over-year; TTM through Dec 2022 was $7987.0, a N/A change, with the full-year FY2025 number at $19302.0, changed N/A from a year prior.
Capital Expenditures hit $7987.0 in Q1 2022 for Healthy Extracts, down from $22985.0 in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $22985.0 in Q1 2019 to a low of $7987.0 in Q1 2022.